EmerRx Biopharma
Biotechnology Research • 
1000 Atlantic Ave, Suite #110, United States • 1-10 Employees
Company overview
| Headquarters | 1000 Atlantic Ave, Suite #110, Alameda, CA 94501, US |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at EmerRx Biopharma
Mitch Raponi
Chief Executive Officer
EmerRx Biopharma Email Formats
EmerRx Biopharma uses 2 email formats. The most common is {first initial} (e.g., j@emerrx.com), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@emerrx.com | 75% |
{first name} | john@emerrx.com | 25% |
About EmerRx Biopharma
Emerrx Biopharma is a preclinical-stage startup developing next-generation intranasal drug delivery technologies. Our lead program is a breakthrough intranasal naloxone with an IV-like pharmacokinetic profile, designed to address the opioid overdose crisis with faster and more effective rescue. Built on a proprietary platform, our approach has broad potential for other emergency and CNS drug applications.
EmerRx Biopharma revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
EmerRx Biopharma has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
EmerRx Biopharma has never raised funding before.
Costa Rica
Netherlands
United Arab Emirates
Australia
South AfricaFrequently asked questions
4.8
40,000 users
